This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MacDonald, M. B.
Right arrow Articles by Wilson, T. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MacDonald, M. B.
Right arrow Articles by Wilson, T. W.
Related Collections
Right arrow Hypertension
Right arrow Psychology
Right arrow Patient-caregiver communication
CMAJ • August 10, 1999; 161 (3)
© 1999 Canadian Medical Association or its licensors


Evidence
Études

Prevalence and predictors of white-coat response in patients with treated hypertension

Mary B. MacDonald, RN, MCEd, Gail P. Laing, RN, PhD, Merne P. Wilson, RN, BSN and Thomas W. Wilson, MD

From (MacDonald, Laing) the College of Nursing and (Wilson) the Departments of Pharmacology and Medicine, College of Medicine, University of Saskatchewan, Saskatoon, Sask., and (Wilson) the Department of Medicine, Royal University Hospital, Saskatoon, Sask.

Abstract

Background: White-coat response, defined as higher office blood pressure readings than ambulatory readings, is common. Few studies have estimated its prevalence among subjects with treated hypertension, and almost none have defined its determinants. The objective of this study was to estimate the prevalence of white-coat response among subjects with treated hypertension and to determine whether the phenomenon could be predicted using clinical and psychometric data.

Methods: A total of 103 treated patients (55 men and 48 women) with uncontrolled hypertension who attended a hypertension outpatient clinic in Saskatoon between September 1993 and December 1995 were entered into the study. Patients had at least 2 clinic blood pressure readings of 140/90 mm Hg or higher, had no target organ damage or left ventricular hypertrophy, and had been prescribed 2 or more classes of antihypertensive drugs. Patients had blood pressure measured in the supine position in the clinic, were placed on 24-hour ambulatory blood pressure monitoring and then completed questionnaires before returning to the clinic. Patients were classified as exhibiting a white-coat response if their mean daytime ambulatory systolic/diastolic blood pressure was 139/89 mm Hg (both) or less, or if the systolic/diastolic pressure was at least 20/15 mm Hg (both) lower than the clinic reading.

Results: Eleven men (20%, 95% confidence interval [CI] 10%-33%) and 26 women (54%, 95% CI 39%-69%) showed white-coat response. Logistic regression modelling showed that determinants such as stress had significantly different effects among men and women. Separate models were therefore created for men and women. For women, perceived level of stress was the most important predictor of white-coat response (odds ratio [OR] per unit 7.0, 95% CI 1.3-36.0), followed by time since diagnosis. For men, depression was a weak predictor, with higher depression scores predicting sustained hypertension (OR per unit 1.2, 95% CI 1.01-1.5).

Interpretation: Sex is an important factor in white-coat response. Attempts to predict white-coat response from psychometric variables should take sex differences into account. Clinical variables were not effective as predictors of white-coat response.





This article has been cited by other articles:


Home page
J Am Board Fam MedHome page
F. A. Augustovski, C. B. Calvo, M. Deprati, and G. Waisman
The Deep-Breath Test as a Diagnostic Maneuver for White-Coat Effect in Hypertensive Patients
J Am Board Fam Med, May 1, 2004; 17(3): 184 - 189.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Romundstad, J. Holmen, H. Hallan, K. Kvenild, and H. Ellekjaer
Microalbuminuria and All-Cause Mortality in Treated Hypertensive Individuals: Does Sex Matter?: The Nord-Trondelag Health Study (HUNT), Norway
Circulation, December 2, 2003; 108(22): 2783 - 2789.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
F. A McAlister and S. E Straus
Evidence based treatment of hypertension: Measurement of blood presssure: an evidence based review
BMJ, April 14, 2001; 322(7291): 908 - 911.
[Full Text]


Home page
CMAJHome page
J. D. Spence
Withholding treatment in white-coat hypertension: wishful thinking
Can. Med. Assoc. J., August 1, 1999; 161(3): 275 - 276.
[Full Text] [PDF]